Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2016-12-19

FDA Approved: AXUMIN — Supplemental Application (Blue Earth Diagnostics)

View source ↗

Summary

The FDA approved a supplemental application for AXUMIN (fluciclovine F-18) submitted by Blue Earth Diagnostics.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Axumin (fluciclovine F-18)

Snippet

SUPPL AP for AXUMIN (FLUCICLOVINE F-18)